MAP2K7 and neuroblastoma: Strong negative feedback, as we detected in the parental neuroblastoma cell lines, is a known resistance mechanism against MEK inhibitors since it results in an accumulation of phosphorylated MEK leading to reactivation of downstream targets [49, 50].